1Tung A,Maliniak K’Tenicela R,et al.Intrathecal morphine for intraoperative and postoperative analgesia.JAMA,1980’244:2637-2638.
2Prager JI, Deer T, Levy R,et al. Best Practices for Intrathecal Drug Delivery for Pain.Neuromodulation,2014,17(4):268-269.
3Sjoberg M,Karlsson PA,Nordborg C,et al .Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients.Anesthesiology,1992,76:173-186.
4Kroin js,Ali A,York M,et al.The distribution of medication along the spinal canal after chronic intrathecal administration.Neurosurgery, 1993,33:226-230.
5Follett KA,Hitchon PW,Piper J,et al.Response Of intractable pain to continuous intrathecal morphineta retrospective study.Pain,1992,49:21-25.
6Smith TJ, Staats PS, Deer T, et al.For the Implantable Drug Delivery Systems Study Group:Randomized clinical trial of an implantable drug deliverysystem compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol, 2002,20:4040-4049.
7Smith MT,Wright AW,Williams BE,et al.Cerebrospinal fluid and plasma concentrations of morphine,morphine-3-glu-curonide and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.Anesth Analgl1999,88(3):109-116.
8Cramond T.Stuart G.Intraventricular morphine for intractahie pain of advanced cancer .J Pain Symptom Manage, 1993,8(7) :465-473.
2Huang B, YAO M, Feng ZY, et al. CT-guided percutaneous infrazygo- matic radiofrequency neurolysis though foramen rotundum to treat V2 trigeminal neuralgia[ J ]. Pain Medicine ,2014,15 ( 8 ) : 1418-1428.
3Huang B, Sun K, Zhu Z, et al. Oximetry-derived perfusion index as an early indicator of CT-guided thoracic sympathetic blockade in palmar hyperhidrosis[ J]. Clinical Radiology ,2013,68 ( 12 ) : 1227-1232.
